Southland Equity Partners LLC Novartis Ag Transaction History

Southland Equity Partners LLC

  • $411 Billion
  • Q3 2024

A detailed history of Southland Equity Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Southland Equity Partners LLC holds 2,999 shares of NVS stock, worth $294,951. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,999
Previous 2,781 7.84%
Holding current value
$294,951
Previous $296 Million 16.51%
% of portfolio
0.08%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$106.13 - $120.89 $23,136 - $26,354
218 Added 7.84%
2,999 $345 Million
Q2 2024

Jul 12, 2024
SELL
$92.57 - $107.37 $20,087 - $23,299
-217 Reduced 7.24%
2,781 $296 Million
Q1 2024

Apr 12, 2024
BUY
$95.27 - $108.47 $3,048 - $3,471
32 Added 1.08%
2,998 $290 Million
Q4 2023

Jan 09, 2024
BUY
$92.27 - $101.54 $2,029 - $2,233
22 Added 0.75%
2,966 $299 Million
Q3 2023

Jan 02, 2024
BUY
$94.73 - $105.13 $9,283 - $10,302
98 Added 3.44%
2,944 $300 Million
Q2 2023

Jan 02, 2024
BUY
$92.52 - $104.91 $14,063 - $15,946
152 Added 5.64%
2,846 $287 Million
Q1 2023

Jan 02, 2024
BUY
$80.03 - $92.81 $4,481 - $5,197
56 Added 2.12%
2,694 $248 Million
Q4 2022

Jan 02, 2024
BUY
$75.55 - $92.52 $199,300 - $244,067
2,638 New
2,638 $239 Million
Q3 2022

Jan 02, 2024
SELL
$74.61 - $87.26 $178,392 - $208,638
-2,391 Closed
0 $0
Q2 2022

Jan 02, 2024
BUY
$80.52 - $93.75 $192,523 - $224,156
2,391 New
2,391 $202 Million
Q1 2022

Jan 02, 2024
SELL
$80.11 - $90.62 $187,297 - $211,869
-2,338 Closed
0 $0
Q4 2021

Jan 02, 2024
BUY
$79.7 - $88.13 $186,338 - $206,047
2,338 New
2,338 $205 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Southland Equity Partners LLC Portfolio

Follow Southland Equity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Southland Equity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Southland Equity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email